Related Experiment Video
Updated: Jul 4, 2026
06:50
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Autoimmune liver serology: current diagnostic and clinical challenges
Dimitrios-P Bogdanos1, Pietro Invernizzi, Ian-R Mackay
1Institute of Liver Studies, King's College London School of Medicine, London SE5 9RS, UK.
World Journal of Gastroenterology
|June 6, 2008
Summary
Accurate diagnosis of autoimmune liver diseases relies on specific autoantibodies. This review examines global quality assurance trends for liver diagnostic serology kits and interpretation.
Area of Science:
- Immunology
- Hepatology
- Clinical Diagnostics
Background:
- Autoimmune liver diseases (AiLD) require precise serological markers for diagnosis and classification.
- Key AiLDs include autoimmune hepatitis (AIH) types 1 and 2, primary biliary cirrhosis (PBC), and sclerosing cholangitis variants.
- Specific autoantibodies like ANA, SMA, anti-LKM1, anti-LC1, AMA, and p-ANCA are crucial for differentiating these conditions.
Purpose of the Study:
- To review the role of liver-related autoantibodies in diagnosing autoimmune liver diseases.
- To explore emerging autoantigens and automated technologies in liver diagnostic serology.
- To survey global quality assurance trends impacting manufacturers, laboratories, and clinicians.
Main Methods:
- Literature review of autoantibodies associated with AIH, PBC, and sclerosing cholangitis.
- Analysis of novel diagnostic technologies including ELISAs and bead assays.
- Examination of quality assurance frameworks in liver diagnostic serology.
Main Results:
- AIH-1 is associated with anti-nuclear antibody (ANA) and smooth muscle antibody (SMA).
- AIH-2 is characterized by antibody to liver kidney microsomal antigen type-1 (anti-LKM1) and anti-liver cytosol type 1 (anti-LC1).
- PBC involves antimitochondrial antibodies (AMA) and specific ANA, while PSC/ASC have distinct serological profiles (e.g., p-ANCA).
- Advancements in technology are enhancing diagnostic capabilities.
Conclusions:
- Liver diagnostic serology is evolving with new antigens and automated platforms.
- Quality assurance is critical across the entire diagnostic chain, from kit production to clinical interpretation.
- Standardized quality assurance ensures reliable diagnosis and management of autoimmune liver diseases.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...